The Increased Adoption Of Artificial Intelligence Is Anticipated To Open Up The New Avenue For Digital Pathology Market

Digital Pathology Market Size
Digital Pathology Market Size


The Digital Pathology Market is estimated to be valued at US$ 884.4 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Digital pathology refers to using digitized slides in diagnostic pathology. Pathologists use scanners to capture digitized slides and digital slide imaging systems to view and analyze high resolution images on computer monitors. Digital pathology offers various advantages over traditional microscopy such as managing large volume of data, remote diagnosis, and education.

Market Dynamics:
The growth of the global digital pathology market is driven by increasing prevalence of cancer and other chronic diseases which requires robust pathologic examination. According to World Health Organization (WHO), cancer burden rose to 19.3 million new cases and 10 million cancer deaths in 2020. This growing disease burden will increase demand for advanced pathology evaluation methods like digital pathology . Secondly, digital pathology solution provides benefits like real-time collaboration, speedy report turnaround, and less resource intensive compared to traditional microscopy. This drives hospitals and diagnostic labs to adopt digital pathology to improve workflow and quality of diagnosis.
Segment Analysis
The global Digital Pathology Market Size is dominated by the software segment. This is owing to the rising adoption of digital pathology solutions like image analysis software and integrated platforms by pathology laboratories and hospitals to improve workflow efficiency. The image analysis software sub-segment currently holds the largest market share and this dominance is expected to continue over the forecast period. This is due to the rising demand for advanced image analysis tools to quantify biomarkers, detect cancerous tissues, and streamline diagnosis.

PEST Analysis
Political: Governments worldwide are promoting digital healthcare solutions to improve diagnostic accuracy and ensure quality control of histopathology tests. Favorable reimbursement policies are also boosting market growth.
Economic: The rising healthcare expenditure across countries and growing focus on lowering diagnostic costs are driving investments in digital pathology systems.
Social: Increasing incidence of cancer and growing awareness about precision diagnostics are fueling the demand for more efficient diagnostic methods like digital pathology.
Technological: Advancements in WSI, AI, big data analytics, and cloud computing are supporting the adoption of digital pathology solutions. Collaborations between digital pathology providers and tech giants are further expanding applications.

Key Takeaways
The global digital pathology market size was valued at US$ 884.4 Mn in 2023 and is expected to reach over US$ 4 Bn by 2030, expanding at a formidable CAGR of 12%. North America currently holds the largest share in the market owing to rapid technological adoption and presence of key players in the region. The increasing workload of pathologists as a result of rise in biopsy procedures and cancer cases is a major factor fueling demand in the region.
With digital pathology gaining traction in molecular diagnostics, drug discovery, and biomarker research, key players are actively focusing on integrating AI and machine learning capabilities in their solutions. Offerings with artificial intelligence have the potential to transform cancer diagnosis by enabling computer-assisted disease classification from digitized slides.
Key players operating in the digital pathology market are Leica Biosystems Nussloch GmbH, Â Olympus Corporation, Â F. Hoffmann-La Roche Ltd., Â Merck KGaA, Â GE Healthcare, Â Mikroscan Technologies, Inc., Â Koninklijke Philips N.V., Â Sectra AB, Â Propath UK Limited, Â Inspirata, Inc., Â Hamamatsu Photonics, Inc., Â OracleBio Limited, Â MD Biosciences, Â Aiforia, Â Xybion Digital Inc., Â Nucleai, Inc. These companies are focusing on new product launches and acquisitions to strengthen their market position.

 

Read More: https://www.rapidwebwire.com/digital-pathology-market-scope/

Post a Comment

Previous Post Next Post